![FTC: Market Consolidation Allows Middlemen to Hike Drug Prices](/content/images/size/w600/2024/07/26903fb9-02b8-4e20-8919-914dd46b093b.png)
Finance
FTC: Market Consolidation Allows Middlemen to Hike Drug Prices
The Federal Trade Commission (FTC) has accused pharmacy benefit managers (PBMs) of significantly influencing prescription drug prices through market consolidation. According to the FTC, the three largest PBMs, which manage 79% of U.S. prescription drug claims, have enriched themselves at the expense of smaller pharmacies and consumers by potentially